SARAH TRIPP: Open Payments
NPI 1538417548 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,967 in 100 payments from 21 companies in 2025. Trend: 2023 $721 · 2024 $693 · 2025 $1,967
Food & beverage: $1,967
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $438 |
| Novo Nordisk Inc | 17 | $375 |
| ABBVIE INC. | 17 | $154 |
| Amgen Inc. | 8 | $140 |
| Dexcom, Inc. | 6 | $119 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $113 |
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $61 |
| Abbott Laboratories | 3 | $55 |
| Axsome Therapeutics, Inc. | 3 | $51 |
Products named: Ozempic, AIRSUPRA, BREZTRI, REXULTI, OTEZLA, Dexcom G6 Transmitter, Kerendia, XIFAXAN.
Industry payments across GA — which companies pay providers there.
